Medically Unexplained Symptoms (MUS) are not only common and distressing, but also are typically poorly managed in general medical settings. Those suffering from these problems tend to incur significantly higher health costs than the general population. There are many effective treatments for different MUS; these are almost entirely based on Cognitive-behavioural approaches. However, the wide range of treatment protocols tend to be "syndrome specific". As such, they do not generalise well in terms of training and application, making them expensive and difficult to disseminate, suggesting the desirability of developing a transdiagnostic approach. The general basis of such a CBT grounded transdiagnostic approach is considered, and the particular need to incorporate cognitive elements of both anxiety/health anxiety (threat) and depression (loss) is highlighted. Key empirically grounded and evidence based processes (both specific and general) previously identified as underpinning the maintenance of MUS are delineated. The way in which these can be combined in a transdiagnostic model which accounts for most MUS presentations is presented and linked to a formulation driven transdiagnostic treatment strategy, which is described.
Medically Unexplained Symptoms (MUS) are an extremely common source of distress and disability for service users attending both primary and secondary health care settings. Those experiencing such problems represent not only a substantial pool of unresolved distress and disability but also a considerable drain on health care resources, which are deployed to no effect or may even worsen their problems in such cases. These patients gain little benefit from current medical treatments, which by definition will be misdirected, and are seldom offered any psychological treatment to help them deal more effectively with these problems. The way in which MUS are presently managed thus represents an expensive failure to meet important health care needs in people where there is evidence of high levels of psychological distress and unnecessary disability. In this paper we consider how we might better understand and treat psychological aspects of MUS. First, we will consider the prevalence and impact of such problems on the health care system and society as a whole, particularly considering economic issues. The issues raised by the wide range of presentations and treatments for MUS are considered, which strongly suggest the need for a more transdiagnostic approach. We therefore describe how they might be conceptualised and treated in psychological terms from an empirically grounded perspective (Salkovskis, 2009) .
MUS are common and costly
Estimates of the prevalence of MUS both in clinical and general populations vary due to the diversity in definitions of as well as diagnostic and operational issues.
Epidemiological studies have shown that MUS are the most common group of symptoms in primary care (Katon, Ries, & Kleinman, 1984) responsible for up 35% of visits in GPs (Peveler, Kilkenny, & Kinmonth, 1997; Simon & VonKorff, 1991) .
Much of the data are specific to particular groups of symptoms; for example prevalence rates for Chronic Fatigue (CF) and Chronic Fatigue Syndrome (CFS) in the adult general population have been estimated at 30.5% and 1.0% respectively with CFS largely unrecognized by GPs (van't Leven, Zielhuis, Jw, Verbeek, & Bleijenberg, 2010) .CFS in primary care ranges from 1.6% to 2,1% (Cho, Menezes, Hotopf, Bhugra, & Wessely, 2009 ) and point prevalence of CF for UK primary care has been estimated at 11.3% (Wessely, Chalder, Hirsch, Wallace, & Wright, 1997) Fibromyalgia estimates are reported to be 2%-2.4% (Mas et al., 2008; Wolfe, Ross, Anderson, Russell, & Hebert, 1995) in the general population , while other studies estimate across community care rates of 1-11% (McBeth & Jones, 2007) . The prevalence of Irritable Bowel Syndrome in Europe and the UK ranges from 8-22% (Müller-Lissner et al., 2001 ) and accounts for 12% of GP consultations (Drossman, Camilleri, Mayer, & Whitehead, 2002) .
Despite the diversity in estimates of MUS there is widespread agreement that such patients consume disproportionately large amounts of healthcare resources across all healthcare settings (Barsky, Orav, & Bates, 2005; Smith, Monson, & Ray, 1986; Wayne Katon, Lin, von Korff, & Russo, 1991; Reynolds, Vernon, Bouchery, & Reeves, 2004; Robinson et al., 2003; Reynolds, et al., 2004) to little effect. Evidence suggests specific use of healthcare resources irrespective of mental or physical comorbidities (Barsky, Orav, & Bates, 2005; Rief, Martin, Klaiberg, & Brähler, 2005; Smith Jr, Monson, & Ray, 1986) . Even so, studies across primary care consistently report that when MUS coexist with mental health problems this leads to increased use of healthcare resources (Haftgoli et al., 2010; Barsky, et al., 2005) . Moreover, MUS patients report many days in bed a month (Smith, et al., 1986) as well as increased rates of sick leave (Hiller et al, 2003) . Bermingham et al. (2010) estimated the cost of medically unexplained somatic symptoms among the working age population in England. They report that indirect costs (i.e. productivity loss) and direct costs (use of health services) from MUS exceeded £14 billion in the fiscal year 2008-9. It is worth noting that Bermingham et al's estimate does not include the full range of MUS, as the authors did not, for instance, include functional somatic syndromes which are reported to have a considerable prevalence among both clinical and non-clinical populations (Hungin, et al., 2005) .
The situation with long term conditions (LTC) is more complex and specific, but the broad principles still apply; where mental health problems co-exist and are not appropriately treated, then patients experience elevated levels of distress and their physical care is both more complex and costly.
What are the treatment options?
Almost by definition, MUS is not a diagnosis, but rather a residual category when other medical diagnoses have been excluded, something which obviously makes these problems difficult to treat in a coherent way. At the same time, little benefit comes from the application of mental health diagnoses such as anxiety and depression as an alternative, despite the clear evidence of comorbidity, as patients understandably regard the focus as being incorrect where such problems are not clearly present. This issue can lead to problems with engagement in such treatment, making engagement a priority in any intervention. Such patients understandably do not view themselves as psychiatrically "ill", but are concerned about their MUS and its implications. Some Health Professionals tend to assume that the full explanation of the range of problems described as MUS will be psychological, but this in the context of the absence of an adequate psychological account of their problems. Sometimes, the group is defined largely in terms of their help seeking behaviour alone e.g."frequent attenders", and it is clear that seeking medical help is common, expensive and of little value for such patients. A more pejorative term, "frequent flyers", has also been used inappropriately.
Fortunately, there is good evidence for the effectiveness of psychological interventions which clearly help people experiencing distressing and disabling levels of MUS. However, although the dominant modality in such treatments is said to be Cognitive-Behavioural Therapy (CBT), this treatment outcome research includes a dismaying variety of flavours, types and variants of CBT, mostly with a highly specialised emphasis and detailed (and different) treatment and training protocols.
Mostly these approaches are specific to particular MUS, but even within narrower groupings a range of often quite different CBT approaches have been used for specific MUS with varying degrees of underpinning evidence. Examples of treatments for specific MUS include (but are not confined to) Chronic Pain, Chronic Fatigue Syndrome, Non-Cardiac Chest Pain, Premenstrual Problems, Breathlessness, Dizzinesss, Insomnia and so on. Although delivering such a diversity of approaches may be feasible in a few larger secondary care settings, it is extremely unlikely that it will be possible to implement the range of such interventions in primary care; a different approach is needed. If it were possible to implement effectively a transdiagnostic approach to helping those experiencing psychological distress linked to the wide range of medically unexplained symptoms, then it would be reasonable to hope that such work could, with some adjustments, be applied to helping those experiencing excessive distress linked to persistent medically explained symptoms, sometimes know and "Long Term Conditions" (LTC). This exciting possibility will be briefly explored later in this paper.
So, whilst it is clear that something more general in CBT terms would make sense from a pragmatic point of view, this needs to be balanced with the clear need to address the specific pattern of symptoms and disability seen in particular MUS. For example, avoidance and anxiety of agoraphobic proportions is often seen in Irritable Bowel syndrome, whilst fatigue and withdrawal from exertion can restrict those with Chronic Fatigue Syndrome (CFS) to an extraordinary degree but for quite different reasons. It seems unlikely that the same therapeutic strategies targeting these superficially similar behavioural restrictions would be effective, whilst it is also evident that there may be some commonalities in terms of the overarching structure of the treatment. On the basis of the way CBT has so successfully developed over the last half century or so, we suggest here that the solution is to adopt a hybrid transdiagnostic/specific approach. To place this in context, we will first consider the historical and conceptual development of transdiagnostic and specific approaches which has resulted in current strategies commonly used in CBT today, and what this tells us about the obstacles to the development and application of a transdiagnostic/specific hybrid treatment in MUS which could also be applied to psychological factors in LTC.
The evolution of Behaviour Therapy into Cognitive-Behaviour Therapy: the admixture of the transdiagnostic and specific.
In mental health settings, psychological approaches to both understanding and treatment has come to be dominated by Behavioural, Cognitive and Cognitive Behavioural theories and their related therapies (described here collectively as CB approaches). There are two factors which most likely explain the almost total shift from "traditional" psychotherapies to CB approaches. Firstly, governments, regulators and health care providers have adopted the principles of evidence based medicine, an approach which readily lends itself to this therapy modality. Secondly, and in our view more importantly, the development of CB approaches has at its heart treatment development and dissemination based on the interplay between psychological theory and research evidence (including but not confined to outcome research), with treatments developing and being applied on the basis not just of evidence based but empirically grounded approaches (Salkovskis 2009 ). Key aspects of problems and how they can be treated have been systematically investigated in the context of established, emerging and developing theories under the broad banners of BT, CT and CBT. Although this set of underpinnings is not specific to these approaches, traditional psychotherapies have more typically tended to develop according to schools of thought and therapy led by authoritative individuals or groups who are mostly unquestioned.
There has been some shift towards embracing evidence in other "schools" of psychotherapy, at least in terms of outcomes (see for example Roth et al, 1996) but the field has been hobbled in terms of further development by its insistence on the primacy of the therapeutic relationship as the principal mechanism of change in therapy. CB approaches, by contrast, are clear that a trusting collaborative relationship is mostly necessary but seldom sufficient. The demonstrable effectiveness of written and computer/online based approaches to therapy (Andersson 2015) has strained the traditional conceptualisation of the therapeutic relationship almost to breaking point.
We suggest here that the therapeutic relationship is a particularly good way of supporting people seeking help in the process of finding different ways of reacting to the situations and events, internal or external, which they find persistently distressing and problematic.
For the present, CB approaches are, for most mental health problems, the treatments of choice, and this type of therapy continues to evolve and be refined (Clark 2004 ).
The use of the plural "treatments" is not accidental. An early transdiagnostic approach to phobic anxiety (Wolpe, 1958) , systematic desensitisation based on the theory of reciprocal inhibition evolved into exposure. Exposure was also applied across phobic anxiety disorders (Marks1979) becoming, in the 1970s more divergent in application and began to include completely new conceptualisations, broadening out from anxiety. Thus, a different approach was indicated for depression, with behavioural (Ferster1973, Seligman, 1972) and cognitive behavioural approaches developing (Beck,1976; Abrahamson, Seligman a& Teasdale, 1978) . The 1980s and 1990s saw a proliferation and expansion of a range of disparate CB approaches, with the development of highly specific treatment for a range of diagnoses both within anxiety (e.g. Panic, Social Phobia, OCD) and more broadly (e.g. Eating Disorders, Chronic Pain, Psychosis) (Hawton et al 1989) .
Whilst it was clear that the development of these increasingly specific treatments was associated with bigger effect sizes relative to earlier versions of treatment, there were also reasons to be concerned for the field as a whole. Instead of learning a single approach to psychological treatment, therapists who wanted to deliver state-of-the-art treatment had to learn multiple approaches, even within diagnostic groupings such as Anxiety Disorders or Eating Disorders (Wilamowska et al, 2010; Fairburn et al, 2003) . As therapies became specialised so also did the therapists, and this in the context of still evolving treatments. Simply put, therapists and health services struggled to keep up. Other issues such as the common problem of comorbidity mean that there are concerns about the development of highly specialist therapists focussing on particular specific problems.
In this climate of proliferating and divergent treatments, clinical researchers began to seek treatments which would bring together the best of the effective treatments without being so specialised. In eating disorders Fairburn and colleagues (Fairburn, Cooper and Shafran, 2003) presented a transdiagnostic theory and related transdiagnostic treatment across eating disorders. Various transdiagnostic approaches to anxiety have been proposed, including those of Norton et al (2012) and David Barlow's Unified Protocol for Emotional Disorders (Wilamowska et al, 2010) .
We are now at an important point in the development of CBT. Specific treatments and transdiagnostic treatments have both been found to be effective to varying degrees.
Thus far, guidelines such as those produced by the National Health Service body NICE tend to favour more specific approaches for each anxiety disorder and depression. However, if taken in the context of stepped care, in which less severe and chronic conditions are treated with "lighter touch" and less focussed treatments than more sever and chronic problems, then it seems that both transdiagnostic and specific approaches may have roles to play without adopting a full on "one size fits all" strategy.
CBT is and isn't transdiagnostic, so it can be applied to MUS Examination of currently recommended CBT approaches to the range of disorders where it is recommended suggests that, having started from common principles set out by Wolpe, Beck and others, there has been some convergence in terms of the fundamental principles underpinning treatment, with differences being mainly in the details of how these principles are applied to each case and type of case. We propose that understanding how to blend in a skilful way these two ways of working is key to the effective treatment of MUS, using a hybrid transdiagnostic/specific approach Treatment thus starts, regardless of the specific problem, with the therapist engaging with the patient, and from this undertaking an assessment which allows them to develop a formulation which should be used as the basis for the development of a shared understanding. The shared understanding will provide the basis for the therapist and client agreeing on strategies which the client can be supported in deploying and evaluating in terms of their impact on their distress and experience of symptoms. This is of course the key to engaging the patient, something which has been described in some detail as successful in the treatment of severe health anxiety where disease conviction is a major issue (Salkovskis et al 2003) . The shared understanding, often referred to as formulation, evolves throughout the course of treatment. In the early stages of therapy it may be more generic, becoming more focussed on particular symptoms as treatment progresses. Towards the later stages of treatment, some strategies will be highly specific to the particular pattern of symptoms and responses experienced by the particular client. Thus, once a preliminary shared understanding is agreed, the basis for more transdiagnostic interventions includes but is not confined to cognitive restructuring (helping patients to identify and change the distorted pattern of thinking and meaning they attach to their symptoms) behavioural activation, exposure to feared situations as behavioural experiments and applied relaxation. The latter stages of treatment focus on more specific aspects of the MUS, such "agoraphobic" type fears in IBS patients who have fears of imminently soiling themselves, beliefs about the potential longer-term catastrophic effects of physical activity in CFS and pain patients and so on.
To achieve a formulation which can be effectively transformed into a shared understanding, we believe that a core model (acting as a template from which some or all of the components can be used to identify key processes) is required. As our starting point, we consider that the cognitive-behavioural model of health anxiety which forms the basis of treatment of those who have excessive anxiety linked to health concerns is likely to be particularly valuable (Salkovskis and Warwick, 1986; Warwick and Salkovskis 1990 ). This treatment has been shown to be effective in those primarily identified as experiencing health anxiety in the absence of significant physical health challenges (e.g. Clark et al, 1998) . More recently, we have shown that the treatment for health anxiety generalises to medical populations screened for the presence of health anxiety even when the therapists were not highly expert in CBT and were trained specifically in the treatment of health anxiety in this setting (Tyrer et al, 2014) .
However, it is also clear from the most cursory consideration of the literature on MUS that health anxiety (or general anxiety), although often important, cannot account for all distress in MUS. For example, although the majority of chronic pain patients experience significant levels of health anxiety, some do not (Rode et al, 2006) .
Although it is not clear as to the extent of health anxiety in CFS, it is likely to be lower than that seen in chronic pain, with other emotions, particularly depression, being prominent. Although CBT models for anxiety, including health anxiety, tend to be transdiagnostic, there are major differences with depression. What is needed, then, is theoretical model similar to those used to guide specific treatments in anxiety and depression which allows the merging of these and other emotional responses in the production of symptom related distress. 
Emotion
Why would some people misinterpret their experience of symptoms and medical issues in a particularly negative way? The cognitive theory suggests that some combination of prior beliefs and experience and the formation of currently unhelpful assumptions is responsible in a complex way (Salkovskis, 1996) ; in treatment terms, however, this is seldom the starting point. The cognitive model also assumes that the extent and severity of emotional response arises from the details of the meaning; However, this perception of meaning (in the case of MUS, typically in terms of illness , disability and disease) relates in turn to a variety of factors; that is The elements in this conceptualisation are: (i) the perceived probability of the feared consequence such as progressively worsening illness; more likely is of course worse;
(ii) how severe this consequence will be (in terms of it's likelihood of disabling, of being ultimately fatal, of interfering with key parts of the person's life and functioning and so on);(iii) how capable the person would be of coping with the illness they believe they have and all of its consequences; and (iv) how likely it would be that other factors would intervene to reduce the severity and the person's ability to cope (such as medical treatment, support from others and so on). For sad or depressed mood, future issues are transposed to past concerns and events or situations which have already happened. What is shown here as Figure 1 is the simplest template for the application of cognitive-behavioural approach to individuals; as indicated below, this template should be used collaboratively to develop a shared understanding, applying those components identified at assessment in the form described by the service user. Such a model also needs to be able to incorporate factors identified as important in maintaining low mood and impairment, starting with the central importance of the interpretation of health-relevant events, information and/or stimuli as particularly negative (including a sense of threat or loss). Here we will apply cognitivebehavioural conceptualisation to MUS/LTC.
These MUS/LTC models need to be empirically grounded and to incorporate factors identified as important in generating and maintaining low mood, anxiety and impairment (both in terms of distress and behaviourally). Given that most models of treatment for which there is an evidence base are cognitive-behavioural and these assume that the interpretation/appraisal of health-relevant events, information and/or stimuli as particularly negative (including a sense of danger, threat or loss), this provides the focus of the present discussion. Typically these appraisal factors are Interpretations and appraisals thus remain key, and drive or motivate some or several categories of largely transdiagnostic maintaining processes which keep the problematic beliefs in place. These maintaining process in turn can and do worsen the negative interpretations and may affect physical as well as psychological functioning.
Broadly these maintaining processes, which need to be identified and dealt with in treatment, have the effect of forming feedback processes ("vicious circles") and include both generalized and more specific factors, although this distinction is at best crude as applied here. 
Specific factors

Generalised Factors
It is also important to recognise a number of generalized vulnerability factors and mechanisms which can lead both to vulnerability to the above maintaining factors and may at times actually mediate them; the extent to which they are present varies somewhat across conditions. These are:
Clinical/negative perfectionism, especially unrelentingly high personal standards and concern about mistakes (social and non-social). Generalised beliefs both in terms of In Figure 1 , for MUS the usual trigger ("Events and Situations") is most likely in MUS to be the perception of a bodily variation, such as feeling fatigued, pain, stomach churning and so on. These may be normal variations or arise from some physical abnormality; it is not necessary in term formulating to distinguish these, although to do so according to the maintaining factors identified above will sometimes be valuable and helpful. It is seldom possible, at least early on in assessment, to identify precisely why this is negatively interpreted, and this usually does not matter unless it is felt appropriate to focus on the general maintaining factors discussed above. Sometimes the source of misinterpretation is more transient, for Reactions: Physiological example, arising from events in the patient's social network or from the mass media, or more enduring but specific, for example from previous experience of physical illhealth in themselves and/or in their families, and previous experience of unsatisfactory medical management in themselves or others. Sometimes there may be obvious assumptions which make the person vulnerable to such appraisals, such as the belief that "bodily changes are usually a sign of serious disease, because every symptom has to have an identifiable physical cause". Such beliefs may also relate to the perception of specific personal weaknesses and particular illnesses; for example, "there's heart trouble in the family", "I've had weak lungs since I was a baby". Such beliefs may be a constant source of anxiety and/or may be activated in vulnerable individuals by critical incidents. Assumptions can also lead the patient to selectively attend to information which appears to confirm the idea of having an illness, and to selectively ignore or discount evidence indicating good health. Thus, particular assumptions often lead to a confirmatory bias in the patient's thinking once a critical incident has resulted in the misinterpretation of bodily symptoms and signs as being indications of serious illness. Further bodily sensations are noticed as a consequence of increased vigilance arising from the appraisal; this forms a feedback loop. Selective attention to illness related information, such as the perception of normal bodily changes (e.g. gastric distension after eating) or previously unnoticed bodily features (e.g. blotchy complexion) is often important. Focussing prompted by worries about health brings slight bodily variations to awareness at times when ideas about illness are already present, leading to a bias towards noticing information that is consistent with the worries about illness, and with any pre-existing confirmatory bias.
In patients who become particularly anxious about their health, such situations are associated with thoughts which represent personally catastrophic interpretations of the bodily sensations or signs. Note that, if the symptoms which are misinterpreted are those which occur as part of anxiety-induced autonomic arousal and the interpretation is that the symptoms are the signs of immediate catastrophe (e.g. "these palpitations mean that I am having a heart attack right now"), a further immediate increase in symptoms will result, resulting in a panic-type reaction, as anxiety worsens the feared sensations apparently confirming the catastrophizing. In any case, Anxiety about health and symptoms themselves is likely to result in physiological arousal. Patients often misinterpret increased autonomic symptoms as further evidence of a physical disease.
Having made a negative appraisal, there is a simple "mood appraisal spiral" effect; the person who thinks negatively experiences strong negative emotions; these strong negative emotions serve to strengthen the negative thinking, worsening the negative emotions in ways familiar from Depression and GAD.
There is a further potential negative effect arising from the emotional response; the experience of negative mood can act as a powerful trigger for past memory, including but not confined to traumatic memories; these memories can directly increase the accessibility of negative thinking, and/or provoke further rumination, probably including preoccupation with issues such as "mental defeat", where the person believes themselves to be undermined as a socially functioning and respected person.
Having made a negative illness or disability related appraisal, most patients then react behaviourally. Such reactions can take several forms; either unhelpful safety seeking behaviour, intended to avoid, check for or totally exclude physical illnesses or attempts to ameliorate the symptoms and their consequences through withdrawal from activities perceived as provoking symptoms. Examples can include avoiding physical exertion, avoiding reminders of disease, seeking reassurance directly from medics or through internet searches, frequent medical consultations, bodily checking, manipulation of areas of the body and repeated inspection). Behaviour occurring as a consequence of perception of threat or harm can further increase negative emotions reactions in a variety of ways. It can keep attention focused on health worries and can therefore result in elaboration of those concerns. It can increase the range and scope of catastrophic interpretations through repeated rumination. Reassurance as provided by others can also increase the scope of worries; for example, the patient who is concerned that his headaches indicate high blood pressure can be misunderstood by his doctor, who tells him that "Your headaches cannot be the sign of a brain tumour; if they were, you would notice dizziness, and would lose your sense of smell". Other examples include a patient who began to check his physical fitness, and found that he was more out of breath than a colleague after climbing some stairs, which he interpreted as a sign that there is something wrong with his lungs. Another patient who checked his throat by repeatedly swallowing to ensure that it was functioning properly; he became convinced that the difficulty he noticed in repeated swallowing meant that he had throat cancer.
In many MUS, the behaviours seen are more about managing symptom intensity; for example, withdrawing from normal physical and social activities because of fatigue or pain, or the perceived risk of consequences of persisting, such as having a bowel accident or a heart attack. Such withdrawal then means that the person has less positive experiences, and may also serve to prevent the person from discovering that the things they fear will not happen. It can also lead to a "boom as bust" pattern as described above.
Note that the formulation "template" depicted here can and should incorporate additional elements including those set out above as specific and general maintaining factors. Also, links across maintaining factors may be present; for example, the link between negative interpretations and perceptions of physical symptoms can be variously mediated by a panic type link, with anxiety directly generating symptoms, behaviours where a slower escalation would be involved, selective attention and increased sensitivity and so on. Additionally, other links between elements are likely to operate in specific instances. The template forms an empirically based starting point which can be developed on a semi-idiographic basis with individual patients as assessment and treatment itself progresses. It can also vary in complexity, from that depicted in the figure both upwards and downwards. In some instances a single vicious circle may be involved, although this would be rare.
Transdiagnostic treatment: A brief overview, stage by stage
To those already working with formulation based CBT, particularly with health anxiety and related problems, treatment principles will be familiar.
1. The overriding principle is that therapy aims to help the patient identify what the problem is rather than to reassure the patient or convince them that "nothing is wrong". In both MUS and LTC physical issues can and should be incorporated into the formulation as a key factor linked directly to the meanings identified.
2. Acknowledge that patients' symptoms by definition really exist, and that adopting a psychological approach does not imply in any sense that symptoms are "imaginary".
Treatment aims to discover satisfactory explanation for the perceived symptoms and more helpful ways of responding to them. This may involve psychological factors in the same way as, for example, tension headaches or a racing heart under stress.
3. Reassurance is part of the problem, not a solution to it. However tempting, giving irrelevant or repetitive information will not help these patients. By definition, they have already have had too much, and it is likely that attempts to reassure will worsen rather than help their problems.
4. Treatment sessions should never become argumentative; the use of questioning as guided discovery is the preferred style, as in cognitive therapy in general.
5. Patients' beliefs are invariably based on evidence which they find convincing; rather than discounting a belief, discover the observations which the patient believes to be evidence of illness and then work collaboratively with the patient on that basis. 6. Treatment is explicitly time-limited on the basis of an agreed contract of therapy intended to fulfil the therapist's requirements whilst respecting the patient's worries about the possible consequences of not pursuing medical treatment.
7. The selective attention and sensitivity to bodily variations typical of many of these patients can be used to demonstrate the way in which anxiety can arise from innocuous circumstances, symptoms and information. This means that within session shifts in affect and symptoms are as important or more important than in other problems. For example, the fact that bringing to mind a threat-related image induced some of the symptoms which are normally interpreted as a sign of cancer is an important demonstration of the validity of the psychological formulation. that patients anxious about their health will misinterpret information discussed within the therapy session. The use of audiotapes of the session for the patients' use helps in this respect, but within-and end of session summaries are also crucial. Where misinterpretation has occurred (as indicated by the summary), then this is another opportunity to provide validation for the alternative explanation, by discussing the occurrence of misinterpretations within the therapy session.
Treatment: stages of understanding and change
The central components and stages of engagement in assessment, assessment itself leading to formulation, engagement in treatment and actual treatment are very similar to those used in common mental health problems, albeit with more explicit attention to engagement issues and with some components of treatment strategies varying according to the particular symptom configuration experienced by the patient and any physical issues at work. That is, some of the specific discussion techniques and behavioural experiments required for Chronic Fatigue as opposed to, say, irritable bowel problems, may vary considerably (although the principles are usually the same). The most substantial variations will tend to come where the predominant emotion is anxiety as opposed to depression. Similarly, in assessment some understanding of the issues experienced by those with such different pattern of symptoms is needed. This is why the treatment is described as a hybrid of transdiagnostic and specific components.
Whether formally or informally, the first stage is screening, problem identification and determination of treatment appropriateness/suitability, often linked to a general clinical assessment. This may be carried out by physical healthcare staff or those involved in offering psychological treatment, according to the setting. At this point where possible screening tools, general measures and assessment specific measures should be used; these can and should used to track progress throughout treatment. See table for a summary of our preferred assessment tools. The first section includes the more general assessments which should be used transdiagnostically, the second those where a particular symptom is present. Note that the table also includes measures which can be used to tap into key maintaining factors as well as specific symptoms. In addition to the importance of monitoring treatment, these more specific measures allow identification of maintaining and tracking of such factors. MUSC is a new self-report measure for MUS developed by members of our group. It measures 7 different types of physical symptoms that seriously interfere with daily life.
Depressive symptoms
Patient health questionnaire (PHQ-9) (Kroenke, Spizer and Williams, 2001) PHQ-9 is 9 item self-report scale that measures depressive symptoms over a two week period prior to answering.
Anxiety symptoms
General Anxiety Disorder -7 (GAD-7) (Spitzer, Kroenke, Williams and Löwe, 2006) GAD-7 is a 7 item self-report scale that screens for and assesses the severity of anxiety symptoms two weeks prior to answering.
Health anxiety Short Health Anxiety Inventory (SHAI) (Salkovskis, Rimes, Warwick and Clark., 2002) SHAI is an 18 item version of the Health Anxiety Inventory that measures health related anxiety.
Disability
The work and social adjustment scale (WSAS) (Mundt et.al., 2002) WSAS is a 5 item self-report scale that measures impaired functioning in everyday activities.
Symptom specific measures
Sleep problems Insomnia Severity Index (ISI) (Bastien, Vallières and Morin, 2001) ISI is a 7 item self-report scale that measures sleep-onset and sleep maintenance difficulties, dissatisfaction with sleep patterns, interference with daily functioning and degree of stress caused by the problem.
Pain problems Brief Pain Inventory (BPI) (Tan et.al., 2004) BPI is an 11 item self-report scale with 4 items that measure pain severity and 7 items that measure pain interference with daily activities.
Treatment proper begins with a full cognitive-behavioural assessment. Such an assessment involves the personal history, development of the problem, and present pattern of symptoms. Fuller engagement takes place at this stage, and is crucial as a two-way process; that is, the therapist getting to know the patient and helping the patient to get to know the therapists. In a real sense, the assessment is a two-way process, with the more important assessment (in terms of engagement) being that of the therapist by the patient! Following this relatively general process, a more focused assessment is used to develop a cognitive-behavioural formulation which includes both etiological and maintaining factors, with the initial primary focus being of the Fatigue and related problems
Chalder Fatigue Scale (Chalder et.al., 1993) The CFS is and 14 item self-report scale that measures physical and mental fatigue.
Gastro-intestinal problems
Irritable Bowel Syndrome Severity Scoring System (IBS-SSS) (Francis, Morris and Whorwell, 1997) IBS-SSS contains 4 items that specifically address IBS symptom severity. These items measure problems with abdominal pain, distension, bowel habits and interference of symptoms with daily life.
Heart and chest symptoms Non-Cardiac Chest Pain Scale (Marks et al, 2014) This measure uses a frequency rating then 8 1-10 ratings of severity, interference and beliefs about chest pain reassurance, which depends on trying to convince the patient that they are not suffering from the illnesses that they fear. Arriving at a formulation of MUS symptoms can be expected to take between one and two sessions.
Because it is the fundamental basis of treatment, the formulation is revised and adapted frequently throughout the treatment period, and is always extended to cover new information which emerges. Once it has been shared, the therapist can progress Discussion techniques and behavioural experiments refer constantly to this formulation as an alternative explanation. The patient is thus helped to make sense of their symptoms from a psychological perspective by a combination of (i) self monitoring of symptoms, their precipitants, behaviour, thoughts and emotional responses; (ii) detailed discussion aimed at helping the patient attribute feared symptoms more accurately; (iii) behavioural experiments which provide the patient with further and especially convincing evidence of the non-threatening and/or counter productive nature of their problems, linked to the shared understanding. As therapy progresses, discussion and behavioural experiments are increasingly used to challenge problematic assumptions about symptoms, illness and health. Behavioural experiments may also focus on helping the person clarify issues around specific physiological factors, such as the development of disuse problems and how these might be overcome, impact of sleep disturbance, problems with "boom and bust" and so on. Where possible, specific reattribution of sensations and symptoms is undertaken, includes discussion strategies and behavioural experiments intended to positively increase belief in psychological components of the formulation. Where appropriate, discrimination between physical and psychological components of sensations/symptoms (and their interaction) will be helpful. Note that this will often require specific knowledge on the part of the therapist.
In many instances, therapy goes on to refocus on more general assumptions or other psychological factors (e.g. perfectionism) which make the patient vulnerable to cognitive distortions. The patient's attention is drawn to the rather more complex nature of their concerns described in the preceding section (probability, cost, coping ability and rescue factors), and therapy may be explicitly directed at the last three as well as the first. Issues such as the basis of the person's self esteem are tackled in this last stage. Attitude change, including dealing with attitudes concerning health, illness and the medical profession. Also challenging beliefs about "awfulness", coping, rescue factors and "superstitious" attitudes and beliefs. Work on perfectionism and cognitive styles such as catastrophizing, Black and white thinking ("all or nothing" ) may also be relevant where these issues are present.
Where relevant, specific attention to excessive medical consultation issues is appropriate.
Although this may have featured to some degree throughout, more specific strategies related to the particular diagnoses may be deployed once the formulation is in place.
The Anxiety of the Clinician
When working with a patient experience physical sensations and bodily variations Applying this rule (and communicating it to other professionals such as family doctor)
should mean that the patient is neither over-investigated nor under-investigated and deals with a fear often expressed by patients, the "cry wolf" problem. Quite early in therapy, patients often express the worry that any real ailment would not be taken sufficiently seriously. If they understand the "rule" described here, then this goes some way towards dealing with these fears.
This could, of course, be taken as meaning that such an approach would apply only in those who are physically healthy. We argue here that this is not so, and indeed our most recent trial of health anxiety treatment was conducted in those being seen in a General Hospital setting and screening positive for health anxiety (Tyrer et al, 2014) .
Where a co-existing physical condition is present, then this is incorporated into the formulation. However, we suggest here that it is possible to go further than this, and offer psychological treatment where the main focus is a primary physical illness.
Long Term Conditions
MUS can also be linked to another major clinical problem, the experience of psychological distress associated with chronic long-term physical conditions (LTC). It seems clear that, in both instances, psychological aspects are crucial in terms of the extent to which those affected perceive themselves as disabled and experiencing poor quality of life related to their experience and interpretation of symptoms, but the application of psychiatric diagnoses are unlikely to be helpful and may indeed be counterproductive.
We therefore consider it likely that better understanding and treatment of MUS is likely to be capable of generalisation to LTC, and we have already begun to apply some of the same principles (Hayter et al 2016) . We have demonstrated that, in people with a diagnosis of Relapsing and Remitting Multiple Sclerosis (RRMS), the extent of perceived disability and impairment of quality of life is very substantially affected by the presence or absence of Health Anxiety. Put simply, those with high health anxiety with no detectable impairment of cognitive and physical function consider themselves to be more impaired that those with lower levels of health anxiety, who in turn are almost identical in terms of their perceptions to the community comparison group. If, as is possible, health anxiety is to some extent driving distress and disability experienced, then it is possible that treatment which seeks to reduce such anxiety may be helpful. This study has been replicated and, in a consecutive single case series, health anxiety was substantially reduced in 4/5 patients with RRMS (Carrigan et al, 2016) . We have since sought to replicate this work in patients with Parkinson's disease, where both cognitive and physical impairment was evident, obtaining similar results in terms of the perception of cognitive impairment (Fixter et al, 2016) .
Interestingly, all participants underestimated the extent of their physical impairment (in a walking task). This suggests that, as in MUS, it may be most appropriate to use a hybrid Transdiagnostic/specific approach to treatment, with adaptations according to the specific LTC involved. There are already a number of studies on providing CBT based psychological help and support to people with specific LTC, indicating that the rationale used for the development of this type of treatment in MUS may generalise well.
Conclusion
We have argued that the development of Transdiagnostic and Specific approaches to CBT have reached the point where it is possible to develop and implement a hybrid approach which should optimise outcomes whilst minimising the additional training and supervision burden. The development of such an approach in MUS has been progressed and is now being piloted, and there are exciting opportunities in terms of future developments for Long-Term Conditions. Quite apart from the likely benefits to patients experiencing disability and distress linked to such problems, there are good reasons to believe that developing this approach as part of stepped care with relatively non-specialist therapists would more than pay for itself.
